On the public citation graph
Challenges in tuberculosis drug research and development
0 signed · 291 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1016/s0140-6736(02)09742-8openalex-snapshot
Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial
inferredcites →https://doi.org/10.1016/s0140-6736(06)68384-0openalex-snapshot
Global epidemiology of tuberculosis
inferredcites →https://doi.org/10.1016/s0140-6736(06)69573-1openalex-snapshot
Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa
inferredcites →https://doi.org/10.1038/35016103openalex-snapshot
A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis
inferredcites →https://doi.org/10.1054/tube.2001.0288openalex-snapshot
Foreword from the Co-Editor-in-Chief
inferredcites →https://doi.org/10.1056/nejmoa055191openalex-snapshot
Outpatient Gatifloxacin Therapy and Dysglycemia in Older Adults
inferredcites →https://doi.org/10.1073/pnas.0508392103openalex-snapshot
Identification of a nitroimidazo-oxazine-specific protein involved in PA-824 resistance in Mycobacterium tuberculosis
inferredcites →https://doi.org/10.1086/505877openalex-snapshot
Global Incidence of Multidrug‐Resistant Tuberculosis
inferredcites →https://doi.org/10.1093/jac/dki319openalex-snapshot
Identification of a new antitubercular drug candidate, SQ109, from a combinatorial library of 1,2-ethylenediamines
inferredcites →https://doi.org/10.1093/jac/dkl227openalex-snapshot
Synergistic interactions of SQ109, a new ethylene diamine, with front-line antitubercular drugs in vitro
inferredcites →https://doi.org/10.1093/jac/dkl260openalex-snapshot
Clinical development of anti-tuberculosis drugs
inferredcites →https://doi.org/10.1097/00002030-200201040-00010openalex-snapshot
Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy
inferredcites →https://doi.org/10.1126/science.1106753openalex-snapshot
A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis
inferredcites →https://doi.org/10.1136/bmj.1.4769.1162openalex-snapshot
Chemotherapy of Pulmonary Tuberculosis in Young Adults
inferredcites →https://doi.org/10.1136/bmj.2.4582.769openalex-snapshot
Streptomycin Treatment of Pulmonary Tuberculosis: A Medical Research Council Investigation
inferredcites →https://doi.org/10.1164/ajrccm.156.3.9609132openalex-snapshot
The Early Bactericidal Activity of Isoniazid Related to Its Dose Size in Pulmonary Tuberculosis
inferredcites →https://doi.org/10.1164/rccm.200407-885ocopenalex-snapshot
Moxifloxacin-containing Regimens of Reduced Duration Produce a Stable Cure in Murine Tuberculosis
inferredcites →https://doi.org/10.1164/rccm.200603-360ocopenalex-snapshot
Moxifloxacin versus Ethambutol in the First 2 Months of Treatment for Pulmonary Tuberculosis
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.5281/zenodo.3591021openalex-extracted
Myths, Realities and Prejudices about Factors Associated with Loss to Follow Up, Relapse and Treatment Failure in Tuberculosis Patients A Qualitative Study
inferred← citeshttps://doi.org/10.1002/9781119951438.eibc2127openalex-snapshot
Metal Specificity of Metallosensors
inferred← citeshttps://doi.org/10.1002/9783527622931.ch3openalex-snapshot
Promising Current Drug Candidates in Clinical Trials and Natural Products Against Multidrug‐Resistant Tuberculosis
inferred← citeshttps://doi.org/10.1002/ajoc.202400482openalex-snapshot
Ligand‐Free Zn Catalyzed Synthesis of Functionalized Indoloacridines
inferred← citeshttps://doi.org/10.1002/ange.201511695openalex-snapshot
Stable Alkynyl Glycosyl Carbonates: Catalytic Anomeric Activation and Synthesis of a Tridecasaccharide Reminiscent of Mycobacterium tuberculosis Cell Wall Lipoarabinomannan
inferred← citeshttps://doi.org/10.1002/ange.202515896openalex-snapshot
Chemical Synthesis of Arabinogalactans from the Mycobacterium tuberculosis Cell Wall up to the 92‐mer and Structure–Conformation–Activity Relationship Studies
inferred← citeshttps://doi.org/10.1002/anie.201511695openalex-snapshot
Stable Alkynyl Glycosyl Carbonates: Catalytic Anomeric Activation and Synthesis of a Tridecasaccharide Reminiscent of Mycobacterium tuberculosis Cell Wall Lipoarabinomannan
inferred← citeshttps://doi.org/10.1002/anie.202515896openalex-snapshot
Chemical Synthesis of Arabinogalactans from the Mycobacterium tuberculosis Cell Wall up to the 92‐mer and Structure–Conformation–Activity Relationship Studies
inferred← citeshttps://doi.org/10.1002/bab.1647openalex-snapshot
Identification of small molecular inhibitors for efflux protein Rv2688c of Mycobacterium tuberculosis
inferred← citeshttps://doi.org/10.1002/cmdc.200800060openalex-snapshot
Exploring Acyclic Nucleoside Analogues as Inhibitors of Mycobacterium tuberculosis Thymidylate Kinase
inferred← citeshttps://doi.org/10.1002/cmdc.201000137openalex-snapshot
Inhibition Studies of Mycobacterium tuberculosis Salicylate Synthase (MbtI)
inferred← citeshttps://doi.org/10.1002/cmdc.201100606openalex-snapshot
Elucidation of Mycobacterium tuberculosis Type II Dehydroquinase Inhibitors using a Fragment Elaboration Strategy
inferred← citeshttps://doi.org/10.1002/cmdc.201900289openalex-snapshot
Azaaurones as Potent Antimycobacterial Agents Active against MDR‐ and XDR‐TB
inferred← citeshttps://doi.org/10.1002/cmdc.202300410openalex-snapshot
Structural Optimization of Antimycobacterial Azaaurones Towards Improved Solubility and Metabolic Stability
inferred← citeshttps://doi.org/10.1002/ddr.22063openalex-snapshot
Natural products and their analogues acting against Mycobacterium tuberculosis : A recent update
inferred← citeshttps://doi.org/10.1002/ddr.70109openalex-snapshot
Functionalized Polydopamine Nanoparticles: A Promising Drug Delivery Platform for the Treatment of Tuberculosis
inferred← citeshttps://doi.org/10.1002/ejoc.202000834openalex-snapshot
Ir(I)‐Catalyzed Synthesis of (E)‐4‐Benzylidenylacridines and (E)‐2‐Styrylquinoline‐3‐carboxamide through Sequential Suzuki–Miyaura Coupling, Dehydrogenative Friedländer Reaction, and sp3‐C–H Activation
inferred← citeshttps://doi.org/10.1002/ejoc.202100613openalex-snapshot
Chemical Synthesis of the Nucleoside Antibiotic Capuramycin
inferred← citeshttps://doi.org/10.1002/med.21602openalex-snapshot
An overview of new antitubercular drugs, drug candidates, and their targets
inferred← citeshttps://doi.org/10.1002/psp4.12591openalex-snapshot
Pretomanid dose selection for pulmonary tuberculosis: An application of multi‐objective optimization to dosage regimen design
inferred← citeshttps://doi.org/10.1002/sim.9314openalex-snapshot
An order restricted multi‐arm multi‐stage clinical trial design
inferred← citeshttps://doi.org/10.1002/slct.202402933openalex-snapshot
Isoniazid Hybrids As Potential Antitubercular Agents
inferred← citeshttps://doi.org/10.1007/978-1-0716-3243-7_3openalex-snapshot
Isolation and Purification of Mycobacterial Extracellular Vesicles (EVs)
inferred← citeshttps://doi.org/10.1007/978-1-4614-1400-1_22openalex-snapshot
Drug Resistant and Persistent Tuberculosis: Mechanisms and Drug Development
inferred← citeshttps://doi.org/10.1007/978-3-030-01751-4_15-1openalex-snapshot
Mycobacterium tuberculosis in Transplantation
inferred← citeshttps://doi.org/10.1007/978-3-030-25869-6_15openalex-snapshot
Mycobacterium tuberculosis in Transplantation
inferred← citeshttps://doi.org/10.1007/978-3-031-15955-8_51openalex-snapshot
Tuberculosis: Integrated Studies for a Complex Disease 2050
inferred← citeshttps://doi.org/10.1007/978-3-7091-1419-3_13openalex-snapshot
TB Vaccines: State of the Art and Progresses
inferred← citeshttps://doi.org/10.1007/978-981-19-3995-2_12openalex-snapshot
Clinical Trials of TB: Challenges and Opportunities
inferred← citeshttps://doi.org/10.1007/s00044-012-0348-8openalex-snapshot
Modeling of antitubercular activity of biphenyl analogs of 2-nitroimidazo[2,1-b][1,3]oxazine to rationalize their activity profile
inferred← citeshttps://doi.org/10.1007/s00203-025-04393-1openalex-snapshot
Unveiling the potential of antimicrobial peptides to combat Mycobacterium tuberculosis
inferred← citeshttps://doi.org/10.1007/s00203-025-04464-3openalex-snapshot
A comprehensive review of advanced strategies to combat antimicrobial resistance
inferred← citeshttps://doi.org/10.1007/s10405-010-0404-3openalex-snapshot
Neue Ansätze in der Therapie der Tuberkulose
inferred← citeshttps://doi.org/10.1007/s10822-010-9399-4openalex-snapshot
Computer-assisted combinatorial design of bicyclic thymidine analogs as inhibitors of Mycobacterium tuberculosis thymidine monophosphate kinase
inferred← citeshttps://doi.org/10.1007/s11418-015-0937-1openalex-snapshot
In vitro antituberculosis activity of diterpenoids from the Vietnamese medicinal plant Croton tonkinensis
inferred← citeshttps://doi.org/10.1007/s12026-022-09284-xopenalex-snapshot
Reverse vaccinology approach to design a multi-epitope vaccine construct based on the Mycobacterium tuberculosis biomarker PE_PGRS17
inferred← citeshttps://doi.org/10.1007/s13312-019-1503-9openalex-snapshot
What is New in Management of Pediatric Tuberculosis ?
inferred← citeshttps://doi.org/10.1007/s42832-023-0222-2openalex-snapshot
Prevention and control strategies for antibiotic resistance: from species to community level
inferred← citeshttps://doi.org/10.1016/b978-0-12-396492-2.00021-7openalex-snapshot
Nonfluoroquinolone-Based Inhibitors of Mycobacterial Type II Topoisomerase as Potential Therapeutic Agents for TB
inferred← citeshttps://doi.org/10.1016/b978-0-443-36518-8.00003-5openalex-snapshot
Drug combinations: A strategy to extend the life of antimicrobials
inferred← citeshttps://doi.org/10.1016/b978-008045382-8.00173-8openalex-snapshot
Structure and Biosynthesis of the Mycobacterial Cell Wall
inferred← citeshttps://doi.org/10.1016/j.aca.2018.04.064openalex-snapshot
Rapid screening drug susceptibility test in tuberculosis using sandwich electrochemical immunosensor
inferred← citeshttps://doi.org/10.1016/j.bbapap.2016.09.008openalex-snapshot
Nickel impact on human health: An intrinsic disorder perspective
inferred← citeshttps://doi.org/10.1016/j.bbrc.2011.07.014openalex-snapshot
An ArsR-like transcriptional factor recognizes a conserved sequence motif and positively regulates the expression of phoP in mycobacteria
inferred← citeshttps://doi.org/10.1016/j.bcp.2013.05.004openalex-snapshot
Inhibition of mycobacterial alanine racemase activity and growth by thiadiazolidinones
inferred← citeshttps://doi.org/10.1016/j.biopha.2014.10.007openalex-snapshot
Quinoline: A promising antitubercular target
inferred← citeshttps://doi.org/10.1016/j.biopha.2017.09.036openalex-snapshot
Cell wall: A versatile fountain of drug targets in Mycobacterium tuberculosis
inferred← citeshttps://doi.org/10.1016/j.biopha.2018.01.115openalex-snapshot
Recent therapeutic approaches for the management of tuberculosis: Challenges and opportunities
inferred← citeshttps://doi.org/10.1016/j.biopha.2018.04.176openalex-snapshot
Drug targets exploited in Mycobacterium tuberculosis: Pitfalls and promises on the horizon
inferred← citeshttps://doi.org/10.1016/j.bios.2020.112890openalex-snapshot
Rapid antimicrobial susceptibility tests on an integrated microfluidic device for precision medicine of antibiotics
inferred← citeshttps://doi.org/10.1016/j.bjbas.2017.07.005openalex-snapshot
A review on quinoline hydrazone derivatives as a new class of potent antitubercular and anticancer agents
inferred← citeshttps://doi.org/10.1016/j.bmc.2008.07.070openalex-snapshot
Quantitative structure–activity relationship studies on nitrofuranyl anti-tubercular agents
inferred← citeshttps://doi.org/10.1016/j.bmc.2011.05.028openalex-snapshot
Evaluation of NTF1836 as an inhibitor of the mycothiol biosynthetic enzyme MshC in growing and non-replicating Mycobacterium tuberculosis
inferred← citeshttps://doi.org/10.1016/j.bmc.2013.07.003openalex-snapshot
Inhibition of Mycobacterium tuberculosis strains H37Rv and MDR MS-115 by a new set of C5 modified pyrimidine nucleosides
inferred← citeshttps://doi.org/10.1016/j.bmc.2015.04.063openalex-snapshot
The relationship between target-class and the physicochemical properties of antibacterial drugs
inferred← citeshttps://doi.org/10.1016/j.bmc.2018.07.049openalex-snapshot
A novel synthesis of 2-arylbenzimidazoles in molecular sieves-MeOH system and their antitubercular activity
inferred← citeshttps://doi.org/10.1016/j.bmcl.2011.05.054openalex-snapshot
Synthesis and antitubercular evaluation of amidoalkyl dibenzofuranols and 1H-benzo[2,3]benzofuro[4,5-e][1,3]oxazin-3(2H)-ones
inferred← citeshttps://doi.org/10.1016/j.bmcl.2011.09.094openalex-snapshot
Novel inhibitors of Mycobacterium tuberculosis dTDP-6-deoxy-l-lyxo-4-hexulose reductase (RmlD) identified by virtual screening
inferred← citeshttps://doi.org/10.1016/j.bmcl.2013.06.076openalex-snapshot
Synthesis and binary QSAR study of antitubercular quinolylhydrazides
inferred← citeshttps://doi.org/10.1016/j.bmcl.2016.11.084openalex-snapshot
Recent advancements in the development of anti-tuberculosis drugs
inferred← citeshttps://doi.org/10.1016/j.carres.2011.05.024openalex-snapshot
Design and synthesis of novel cell wall inhibitors of Mycobacterium tuberculosis GlmM and GlmU
inferred← citeshttps://doi.org/10.1016/j.ccm.2009.08.011openalex-snapshot
Toward an Optimized Therapy for Tuberculosis? Drugs in Clinical Trials and in Preclinical Development
inferred← citeshttps://doi.org/10.1016/j.cell.2010.02.012openalex-snapshot
Genome-wide Analysis of the Host Intracellular Network that Regulates Survival of Mycobacterium tuberculosis
inferred← citeshttps://doi.org/10.1016/j.cels.2021.08.004openalex-snapshot
Systematic measurement of combination-drug landscapes to predict in vivo treatment outcomes for tuberculosis
inferred← citeshttps://doi.org/10.1016/j.colsurfb.2017.09.036openalex-snapshot
Assessment of halloysite nanotubes as vehicles of isoniazid
inferred← citeshttps://doi.org/10.1016/j.drudis.2007.08.001openalex-snapshot
Combined therapy for tuberculosis and HIV-1: the challenge for drug discovery
inferred← citeshttps://doi.org/10.1016/j.drudis.2012.05.014openalex-snapshot
WITHDRAWN: Enabling infrastructure for global health product development
inferred← citeshttps://doi.org/10.1016/j.drudis.2012.06.006openalex-snapshot
WITHDRAWN: Maintaining the momentum of antitubercular drug discovery
inferred← citeshttps://doi.org/10.1016/j.drudis.2016.09.004openalex-snapshot
The implications of model-informed drug discovery and development for tuberculosis
inferred← citeshttps://doi.org/10.1016/j.ejmech.2010.09.056openalex-snapshot
Design, synthesis and inhibitory activity against Mycobacterium tuberculosis thymidine monophosphate kinase of acyclic nucleoside analogues with a distal imidazoquinolinone
inferred← citeshttps://doi.org/10.1016/j.ejmech.2011.06.014openalex-snapshot
Synthesis and antitubercular evaluation of novel dibenzo[b,d]furan and 9-methyl-9H-carbazole derived hexahydro-2H-pyrano[3,2-c]quinolines via Povarov reaction
inferred← citeshttps://doi.org/10.1016/j.ejmech.2011.07.046openalex-snapshot
Synthesis of 3-heteroarylthioquinoline derivatives and their in vitro antituberculosis and cytotoxicity studies
inferred← citeshttps://doi.org/10.1016/j.ejmech.2014.04.017openalex-snapshot
Synthesis, crystal studies, anti-tuberculosis and cytotoxic studies of 1-[(2E)-3-phenylprop-2-enoyl]-1H-benzimidazole derivatives
inferred← citeshttps://doi.org/10.1016/j.ejmech.2014.07.051openalex-snapshot
Design, synthesis and 3D-QSAR studies of new diphenylamine containing 1,2,4-triazoles as potential antitubercular agents
inferred← citeshttps://doi.org/10.1016/j.ejmech.2015.06.017openalex-snapshot
Recent progress in the drug development of coumarin derivatives as potent antituberculosis agents
inferred← citeshttps://doi.org/10.1016/j.ejmech.2016.08.034openalex-snapshot
Mycobacterium Tuberculosis (MTB) GyrB inhibitors: An attractive approach for developing novel drugs against TB
inferred← citeshttps://doi.org/10.1016/j.ejmech.2021.114066openalex-snapshot
Tuberculosis drug discovery: Progression and future interventions in the wake of emerging resistance
inferred← citeshttps://doi.org/10.1016/j.ejps.2018.08.038openalex-snapshot
Chitosan nanoparticles as a promising approach for pulmonary delivery of bedaquiline
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2019.05.108openalex-snapshot
Structure based identification of novel inhibitors against ATP synthase of Mycobacterium tuberculosis: A combined in silico and in vitro study
inferred← citeshttps://doi.org/10.1016/j.ijid.2015.05.006openalex-snapshot
Impact of tuberculosis treatment and antiretroviral therapy on serial RD-1-specific quantitative T-cell readouts (QuantiFERON-TB Gold In-Tube), and relationship to treatment-related outcomes and bacterial burden
inferred← citeshttps://doi.org/10.1016/j.jchromb.2015.10.039openalex-snapshot
Pharmacokinetics and tissue distribution study of PA-824 in rats by LC–MS/MS
inferred← citeshttps://doi.org/10.1016/j.jinf.2019.08.004openalex-snapshot
Is rifampin resistance a reliable predictive marker of multidrug-resistant tuberculosis in China: A meta-analysis of findings
inferred← citeshttps://doi.org/10.1016/j.jiph.2016.11.018openalex-snapshot
Factors contributing to non-adherence with treatment among TB patients in Sodo Woreda, Gurage Zone, Southern Ethiopia: A qualitative study
inferred← citeshttps://doi.org/10.1016/j.mehy.2025.111761openalex-snapshot
The hypothesis – A dual-front attack on TB: Vitamin D–fluoroquinolone conjugates as next generation therapeutic strategy against drug-resistant Mycobacterium tuberculosis
inferred← citeshttps://doi.org/10.1016/j.mib.2011.08.003openalex-snapshot
Combination therapies for combating antimicrobial resistance
inferred← citeshttps://doi.org/10.1016/j.micromeso.2019.109733openalex-snapshot
Adsorption capacity evaluation of zeolites as carrier of isoniazid
inferred← citeshttps://doi.org/10.1016/j.molstruc.2021.130016openalex-snapshot
Design, synthesis, molecular docking and biological activity studies of novel coumarino-azetidinones
inferred← citeshttps://doi.org/10.1016/j.nut.2013.03.018openalex-snapshot
Low plasma levels of cholecalciferol and 13-cis-retinoic acid in tuberculosis: Implications in host-based chemotherapy
inferred← citeshttps://doi.org/10.1016/j.pbiomolbio.2023.04.009openalex-snapshot
An update on ATP synthase inhibitors: A unique target for drug development in M. tuberculosis
inferred← citeshttps://doi.org/10.1016/j.phrs.2017.10.011openalex-snapshot
Antimicrobial peptides as an alternative to anti-tuberculosis drugs
inferred← citeshttps://doi.org/10.1016/j.pupt.2015.05.005openalex-snapshot
In vitro effect of ursolic acid on the inhibition of Mycobacterium tuberculosis and its cell wall mycolic acid
inferred← citeshttps://doi.org/10.1016/j.tim.2007.12.002openalex-snapshot
Preclinical testing of new drugs for tuberculosis: current challenges
inferred← citeshttps://doi.org/10.1016/j.tim.2021.05.005openalex-snapshot
Towards efficient immunotherapy for bacterial infection
inferred← citeshttps://doi.org/10.1016/j.tube.2008.06.001openalex-snapshot
Inhibition of M. tuberculosis in vitro in monocytes and in mice by aminomethylene pyrazinamide analogs
inferred← citeshttps://doi.org/10.1016/j.tube.2010.03.007openalex-snapshot
Early clinical development of anti-tuberculosis drugs: Science, statistics and sterilizing activity
inferred← citeshttps://doi.org/10.1016/j.tube.2011.04.001openalex-snapshot
T lymphocyte surface expression of exhaustion markers as biomarkers of the efficacy of chemotherapy for tuberculosis
inferred← citeshttps://doi.org/10.1016/j.tube.2015.01.005openalex-snapshot
Differential expression of efflux pump genes of Mycobacterium tuberculosis in response to varied subinhibitory concentrations of antituberculosis agents
inferred← citeshttps://doi.org/10.1016/s0140-6736(10)60359-9openalex-snapshot
Global tuberculosis drug development pipeline: the need and the reality
inferred← citeshttps://doi.org/10.1016/s0140-6736(10)60483-7openalex-snapshot
Tuberculosis control and elimination 2010–50: cure, care, and social development
inferred← citeshttps://doi.org/10.1016/s0213-005x(11)70018-0openalex-snapshot
New drugs for tuberculosis treatment
inferred← citeshttps://doi.org/10.1016/s1472-9792(08)70035-0openalex-snapshot
Experimental tuberculosis: the role of comparative pathology in the discovery of improved tuberculosis treatment strategies
inferred← citeshttps://doi.org/10.1016/s1473-3099(10)70201-2openalex-snapshot
Priorities for tuberculosis research: a systematic review
inferred← citeshttps://doi.org/10.1017/s0260210514000345openalex-snapshot
The rise of companies from emerging markets in global health governance: Opportunities and challenges
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.2c00227openalex-snapshot
Tuberculosis Drug Discovery: Challenges and New Horizons
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.5c03631openalex-snapshot
Design, Synthesis, and Antitubercular Activity Evaluation of Novel Nitroimidazole Derivatives
inferred← citeshttps://doi.org/10.1021/acs.joc.5b00964openalex-snapshot
Influence of Steric Crowding on Diastereoselective Arabinofuranosylations
inferred← citeshttps://doi.org/10.1021/acschembio.5b00517openalex-snapshot
First-in-Class Inhibitors of Sulfur Metabolism with Bactericidal Activity against Non-ReplicatingM. tuberculosis
inferred← citeshttps://doi.org/10.1021/acsinfecdis.1c00136openalex-snapshot
Immunotherapeutic Role of NOD-2 and TLR-4 Signaling as an Adjunct to Antituberculosis Chemotherapy
inferred← citeshttps://doi.org/10.1021/acsomega.5c04344openalex-snapshot
Adsorption of Isoniazid on Aluminum Silicate Tubular Structures
inferred← citeshttps://doi.org/10.1021/acsomega.6c04844openalex-snapshot
Atomic-Level Structures Reveal How a Repurposed 3-Aminopyrazine-2-carboxamide Scaffold Inhibits Mycobacterium tuberculosis Prolyl-tRNA Synthetase
inferred← citeshttps://doi.org/10.1021/ci800143nopenalex-snapshot
Global Bayesian Models for the Prioritization of Antitubercular Agents
inferred← citeshttps://doi.org/10.1021/jacs.3c12815openalex-snapshot
One-Pot Assembly of Mannose-Capped Lipoarabinomannan Motifs up to 101-Mer from the Mycobacterium tuberculosis Cell Wall
inferred← citeshttps://doi.org/10.1021/jm070719iopenalex-snapshot
Natural Products, Small Molecules, and Genetics in Tuberculosis Drug Development
inferred← citeshttps://doi.org/10.1021/jm201023gopenalex-snapshot
Design, Synthesis, and Evaluation of Thiol-Activated Sources of Sulfur Dioxide (SO2) as Antimycobacterial Agents
inferred← citeshttps://doi.org/10.1021/jm300125eopenalex-snapshot
Design, Synthesis, and Structure–Activity Correlations of Novel Dibenzo[b,d]furan, Dibenzo[b,d]thiophene, and N-Methylcarbazole Clubbed 1,2,3-Triazoles as Potent Inhibitors of Mycobacterium tuberculosis
inferred← citeshttps://doi.org/10.1021/np400497fopenalex-snapshot
Chlorinated Coumarins from the Polypore Mushroom Fomitopsis officinalis and Their Activity against Mycobacterium tuberculosis
inferred← citeshttps://doi.org/10.1021/ol400931popenalex-snapshot
Facile Synthesis of β- and α-Arabinofuranosides and Application to Cell Wall Motifs of M. tuberculosis
inferred← citeshttps://doi.org/10.1021/pr300345xopenalex-snapshot
Metabolomic Signatures in Guinea Pigs Infected with Epidemic-Associated W-Beijing Strains of Mycobacterium tuberculosis
inferred← citeshttps://doi.org/10.1038/gt.2015.73openalex-snapshot
Inhalation of recombinant adenovirus expressing granulysin protects mice infected with Mycobacterium tuberculosis
inferred← citeshttps://doi.org/10.1038/ncomms14019openalex-snapshot
[Au]/[Ag]-catalysed expedient synthesis of branched heneicosafuranosyl arabinogalactan motif of Mycobacterium tuberculosis cell wall
inferred← citeshttps://doi.org/10.1038/nrmicro1816openalex-snapshot
Drugs versus bugs: in pursuit of the persistent predator Mycobacterium tuberculosis
inferred← citeshttps://doi.org/10.1038/s41420-026-03156-1openalex-snapshot
Characterization of programmed cell death pathways activated in Mycobacterium tuberculosis-infected human macrophages
inferred← citeshttps://doi.org/10.1038/s41573-023-00670-0openalex-snapshot
Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems
inferred← citeshttps://doi.org/10.1038/s41591-024-02829-7openalex-snapshot
A first-in-class leucyl-tRNA synthetase inhibitor, ganfeborole, for rifampicin-susceptible tuberculosis: a phase 2a open-label, randomized trial
inferred← citeshttps://doi.org/10.1038/s41597-022-01631-9openalex-snapshot
PLAS-5k: Dataset of Protein-Ligand Affinities from Molecular Dynamics for Machine Learning Applications
inferred← citeshttps://doi.org/10.1038/s41598-019-40621-7openalex-snapshot
Designing novel possible kinase inhibitor derivatives as therapeutics against Mycobacterium tuberculosis: An in silico study
inferred← citeshttps://doi.org/10.1038/s41598-022-12413-zopenalex-snapshot
In vitro anti-tuberculosis effect of probiotic Lacticaseibacillus rhamnosus PMC203 isolated from vaginal microbiota
inferred← citeshttps://doi.org/10.1038/s41598-024-63051-6openalex-snapshot
Discovery of potent antimycobacterial agents targeting lumazine synthase (RibH) of Mycobacterium tuberculosis
inferred← citeshttps://doi.org/10.1038/s44259-026-00238-zopenalex-snapshot
Antimicrobial peptides for tuberculosis in a post-antibiotic era: from in vitro promise to therapeutic potential
inferred← citeshttps://doi.org/10.1038/srep11910openalex-snapshot
Proteasome Accessory Factor C (pafC) Is a novel gene Involved in Mycobacterium Intrinsic Resistance to broad-spectrum antibiotics - Fluoroquinolones
inferred← citeshttps://doi.org/10.1039/b906682aopenalex-snapshot
Bacterial metal-sensing proteins exemplified by ArsR–SmtB family repressors
inferred← citeshttps://doi.org/10.1039/c0cc05635aopenalex-snapshot
Inhibitors of an essential mycobacterial cell wall lipase (Rv3802c) as tuberculosis drug leads
inferred← citeshttps://doi.org/10.1039/c1mb05106gopenalex-snapshot
Modeling synergistic drug inhibition of Mycobacterium tuberculosis growth in murine macrophages
inferred← citeshttps://doi.org/10.1039/c3ob41896kopenalex-snapshot
Inhibition studies on Mycobacterium tuberculosis N-acetylglucosamine-1-phosphate uridyltransferase (GlmU)
inferred← citeshttps://doi.org/10.1039/c3ra43755hopenalex-snapshot
Design, synthesis, and preliminary biological evaluation of novel ketone derivatives of shikimic acid
inferred← citeshttps://doi.org/10.1039/d5ra03641kopenalex-snapshot
Isoniazid–rhodanine molecular hybrids: design, synthesis, antimycobacterial activity and computational validation
inferred← citeshttps://doi.org/10.1042/bj20080466openalex-snapshot
Characterization of coenzyme binding and selectivity determinants in Mycobacterium tuberculosis flavoprotein reductase A: analysis of Arg199 and Arg200 mutants at the NADP(H) 2′-phosphate binding site
inferred← citeshttps://doi.org/10.1073/pnas.1003219107openalex-snapshot
Mycobacterium tuberculosis persistence mutants identified by screening in isoniazid-treated mice
inferred← citeshttps://doi.org/10.1074/jbc.m112.419069openalex-snapshot
The Naphthoquinone Diospyrin Is an Inhibitor of DNA Gyrase with a Novel Mechanism of Action
inferred← citeshttps://doi.org/10.1074/jbc.m703451200openalex-snapshot
Mycobacterial Cells Have Dual Nickel-Cobalt Sensors
inferred← citeshttps://doi.org/10.1074/jbc.m707535200openalex-snapshot
Interdomain Interaction Reconstitutes the Functionality of PknA, a Eukaryotic Type Ser/Thr Kinase from Mycobacterium tuberculosis
inferred← citeshttps://doi.org/10.1074/jbc.m709672200openalex-snapshot
Three Consecutive Arginines Are Important for the Mycobacterial Peptide Deformylase Enzyme Activity
inferred← citeshttps://doi.org/10.1074/jbc.m805324200openalex-snapshot
Distinct Specificities of Mycobacterium tuberculosis and Mammalian Proteasomes for N-Acetyl Tripeptide Substrates
inferred← citeshttps://doi.org/10.1080/07391102.2023.2226728openalex-snapshot
Copper transporter protein (MctB) as a therapeutic target to elicit antimycobacterial activity against tuberculosis
inferred← citeshttps://doi.org/10.1080/07391102.2023.2245486openalex-snapshot
Computational insights into the role of structurally diverse plant secondary metabolites as inhibitors against Imidazole Glycerol Phosphate Dehydratase of Mycobacterium tuberculosis
inferred← citeshttps://doi.org/10.1080/08927020903033141openalex-snapshot
Comparative QSAR studies of nitrofuranyl amide derivatives using theoretical structural properties
inferred← citeshttps://doi.org/10.1080/1040841x.2022.2035314openalex-snapshot
Biosensors for the detection ofMycobacterium tuberculosis: a comprehensive overview
inferred← citeshttps://doi.org/10.1080/1062936x.2022.2066175openalex-snapshot
Molecular docking-based interactions in QSAR studies on Mycobacterium tuberculosis ATP synthase inhibitors
inferred← citeshttps://doi.org/10.1080/10717544.2022.2089294openalex-snapshot
Emerging strategies in nanotechnology to treat respiratory tract infections: realizing current trends for future clinical perspectives
inferred← citeshttps://doi.org/10.1080/13543776.2022.2012151openalex-snapshot
An updated patent review on drugs for the treatment of tuberculosis (2018-present)
inferred← citeshttps://doi.org/10.1093/femsml/uqae021openalex-snapshot
Pyoverdine–antibiotic combination treatment: its efficacy and effects on resistance evolution in Escherichia coli
inferred← citeshttps://doi.org/10.1093/infdis/jis034openalex-snapshot
New Drugs for the Treatment of Tuberculosis: Needs, Challenges, Promise, and Prospects for the Future
inferred← citeshttps://doi.org/10.1093/infdis/jis425openalex-snapshot
Therapeutic Immunization against Mycobacterium tuberculosis Is an Effective Adjunct to Antibiotic Treatment
inferred← citeshttps://doi.org/10.1093/jac/dkr203openalex-snapshot
Interaction of N-methyl-2-alkenyl-4-quinolones with ATP-dependent MurE ligase of Mycobacterium tuberculosis: antibacterial activity, molecular docking and inhibition kinetics
inferred← citeshttps://doi.org/10.1097/coh.0b013e3282fbaad0openalex-snapshot
Interactions between antiretroviral agents and those used to treat tuberculosis
inferred← citeshttps://doi.org/10.1097/mcp.0b013e328337580copenalex-snapshot
New drugs and new regimens for the treatment of tuberculosis: review of the drug development pipeline and implications for national programmes
inferred← citeshttps://doi.org/10.1097/qad.0b013e3282f7cb4bopenalex-snapshot
Impact of HIV on novel therapies for tuberculosis control
inferred← citeshttps://doi.org/10.1098/rsos.172416openalex-snapshot
Functionalization of 3-chloroformylcoumarin to coumarin Schiff bases using reusable catalyst: an approach to molecular docking and biological studies
inferred← citeshttps://doi.org/10.1099/mic.0.082206-0openalex-snapshot
Mycobacterium tuberculosis adhesins: potential biomarkers as anti-tuberculosis therapeutic and diagnostic targets
inferred← citeshttps://doi.org/10.1101/2023.07.18.549608openalex-snapshot
Elucidation of the essentiality of lumazine synthase (RibH) for Mycobacterium tuberculosis survival and discovery of potent inhibitors for enhanced antimycobacterial therapy
inferred← citeshttps://doi.org/10.1101/2025.11.23.690070openalex-snapshot
Targeting Metabolic Vulnerabilities: Valinomycin Augments the Potency of Bioenergetic Inhibitors in Combatting Drug-Resistant and Dormant Mycobacterium tuberculosis
inferred← citeshttps://doi.org/10.1101/861799openalex-snapshot
Combining antibiotics with antivirulence compounds can have synergistic effects and reverse selection for antibiotic resistance in Pseudomonas aeruginosa
inferred← citeshttps://doi.org/10.1111/ajt.12100openalex-snapshot
Mycobacterium tuberculosis Infections in Solid Organ Transplantation
inferred← citeshttps://doi.org/10.1111/bcp.15908openalex-snapshot
No action is without its side effects: Adverse drug reactions and missed doses of antituberculosis therapy, a scoping review
inferred← citeshttps://doi.org/10.1111/bph.15247openalex-snapshot
Anti‐tuberculosis effect of isoniazid scales accurately from zebrafish to humans
inferred← citeshttps://doi.org/10.1111/cbdd.12527openalex-snapshot
Triazole: A Promising Antitubercular Agent
inferred← citeshttps://doi.org/10.1111/ctr.13513openalex-snapshot
Mycobacterium tuberculosis infections in solid organ transplantation: Guidelines from the infectious diseases community of practice of the American Society of Transplantation
inferred← citeshttps://doi.org/10.1111/j.1399-3062.2008.00332.xopenalex-snapshot
Tuberculosis in transplant recipients: diagnostic and therapeutic dilemmas
inferred← citeshttps://doi.org/10.1111/j.1600-6143.2009.02894.xopenalex-snapshot
Mycobacterium tuberculosis in Solid Organ Transplant Recipients
inferred← citeshttps://doi.org/10.1111/j.1747-0285.2012.01436.xopenalex-snapshot
Evaluation of Structurally Diverse Benzoazepines Clubbed with Coumarins asMycobacterium tuberculosisAgents
inferred← citeshttps://doi.org/10.1126/scitranslmed.adi4000openalex-snapshot
Selection and prioritization of candidate combination regimens for the treatment of tuberculosis
inferred← citeshttps://doi.org/10.1128/aac.00186-22openalex-snapshot
Respirable Clofazimine Particles Produced by Air Jet Milling Technique Are Efficacious in Treatment of BALB/c Mice with Chronic Mycobacterium tuberculosis Infection
inferred← citeshttps://doi.org/10.1128/aac.00366-22openalex-snapshot
Quantitative Systems Pharmacology Modeling Framework of Autophagy in Tuberculosis: Application to Adjunctive Metformin Host-Directed Therapy
inferred← citeshttps://doi.org/10.1128/aac.00692-15openalex-snapshot
Disulfiram and Copper Ions Kill Mycobacterium tuberculosis in a Synergistic Manner
inferred← citeshttps://doi.org/10.1128/aac.00749-08openalex-snapshot
New Drugs against Tuberculosis: Problems, Progress, and Evaluation of Agents in Clinical Development
inferred← citeshttps://doi.org/10.1128/aac.00762-22openalex-snapshot
Novel Antibacterial Activity of Febuxostat, an FDA-Approved Antigout Drug against Mycobacterium tuberculosis Infection
inferred← citeshttps://doi.org/10.1128/aac.00898-22openalex-snapshot
Pharmacodynamics and Bactericidal Activity of Combination Regimens in Pulmonary Tuberculosis: Application to Bedaquiline-Pretomanid-Pyrazinamide
inferred← citeshttps://doi.org/10.1128/aac.01521-09openalex-snapshot
Evaluation of Standard Chemotherapy in the Guinea Pig Model of Tuberculosis
inferred← citeshttps://doi.org/10.1128/jb.00585-12openalex-snapshot
Mycobacterium tuberculosis Protein Kinase K Enables Growth Adaptation through Translation Control
inferred← citeshttps://doi.org/10.1134/s1068162023603257openalex-snapshot
Recent Developments in Structurally Diverse Anti-Tubercular Drug Molecules and Their Molecular Targets Against Mycobacterium tuberculosis
inferred← citeshttps://doi.org/10.1136/thx.2007.090936openalex-snapshot
Tuberculosis and its future management
inferred← citeshttps://doi.org/10.1136/thx.2007.090969openalex-snapshot
The future for lung disease in children
inferred← citeshttps://doi.org/10.1136/thx.2007.091116openalex-snapshot
The BTS and our 25th anniversary
inferred← citeshttps://doi.org/10.1159/000327513openalex-snapshot
Chapter 23: Serial Sputum Colony Counting in Drug Development
inferred← citeshttps://doi.org/10.1164/rccm.202101-0117ocopenalex-snapshot
Precision-Enhancing Risk Stratification Tools for Selecting Optimal Treatment Durations in Tuberculosis Clinical Trials
inferred← citeshttps://doi.org/10.1172/jci34614openalex-snapshot
Confronting the scientific obstacles to global control of tuberculosis
inferred← citeshttps://doi.org/10.1186/1471-2091-12-35openalex-snapshot
Amino-terminal extension present in the methionine aminopeptidase type 1c of Mycobacterium tuberculosis is indispensible for its activity
inferred← citeshttps://doi.org/10.1186/s13063-023-07068-8openalex-snapshot
Implementation challenges and lessons learned from the STREAM clinical trial—a survey of trial sites
inferred← citeshttps://doi.org/10.1186/s13063-025-08887-7openalex-snapshot
The role of stakeholder mapping and engagement in Mongolia during the implementation of the STREAM clinical trial for MDR-TB
inferred← citeshttps://doi.org/10.1208/s12249-023-02510-1openalex-snapshot
Solubility Enhancement and Inhalation Delivery of Cyclodextrin-Based Inclusion Complex of Delamanid for Pulmonary Tuberculosis Treatment
inferred← citeshttps://doi.org/10.1246/cl.130839openalex-snapshot
Task-specific Ionic Liquid-mediated Facile Synthesis of 1,3,5-Triaryltriazines by Cyclotrimerization of Imines and Their Biological Evaluation
inferred← citeshttps://doi.org/10.12688/gatesopenres.13058.1openalex-snapshot
Integrating tuberculosis research with public health infrastructure: Lessons on community engagement from Orizaba, Mexico
inferred← citeshttps://doi.org/10.1371/journal.pbio.3000805openalex-snapshot
Combining antibiotics with antivirulence compounds can have synergistic effects and reverse selection for antibiotic resistance in Pseudomonas aeruginosa
inferred← citeshttps://doi.org/10.1371/journal.pmed.1002769openalex-snapshot
Advances in clinical trial design for development of new TB treatments: A call for innovation
inferred← citeshttps://doi.org/10.1371/journal.pmed.1002915openalex-snapshot
Development of new TB regimens: Harmonizing trial design, product registration requirements, and public health guidance
inferred← citeshttps://doi.org/10.1371/journal.pmed.1003059openalex-snapshot
Advances in clinical trial design: Weaving tomorrow’s TB treatments
inferred← citeshttps://doi.org/10.1371/journal.pone.0020374openalex-snapshot
New Classes of Alanine Racemase Inhibitors Identified by High-Throughput Screening Show Antimicrobial Activity against Mycobacterium tuberculosis
inferred← citeshttps://doi.org/10.1371/journal.pone.0027398openalex-snapshot
Amino Acids Involved in Polyphosphate Synthesis and Its Mobilization Are Distinct in Polyphosphate Kinase-1 from Mycobacterium tuberculosis
showing the first 200 of 273 · page through all 273
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.